
Lumpectomy or Mastectomy? What You Need to Know
Breast cancer treatment options vary from patient to patient. Physicians must weigh many factors when considering which approach is best for a particular patient. Those
HIPAA Alert: Potential Data Breach Learn More
Questions on Oncology, Hematology and/or Infusion Clinical Services due to COVID-19 Crisis – CALL 833-698-1623
Important Information for Our Patients Regarding the Coronavirus.
RCCA Providing Area Cancer Patients with Access to Care During Coronavirus Outbreak
RCCA Offering Patients Virtual Visits During Coronavirus Pandemic
Multiple myeloma (MM) is a rare type of blood cancer that often develops without early symptoms, making awareness of risk factors essential. Regional Cancer Care Associates (RCCA) provides insights on the factors that may increase a person’s likelihood of developing multiple myeloma.
With more than 20 locations across New Jersey, Connecticut, Massachusetts, and the Washington, D.C., area, RCCA is dedicated to keeping patients informed about the latest cancer research and advancements in oncology care.
Certain environmental exposures and lifestyle factors have been linked to multiple myeloma.
Several medical conditions have been associated with a higher likelihood of developing multiple myeloma.
Certain autoimmune diseases have been linked to a higher risk of myeloma, including:
A plasmacytoma is a type of plasma cell tumor that may increase the likelihood of developing multiple myeloma.
Regional Cancer Care Associates (RCCA) provides patients with the latest information on multiple myeloma and other blood cancers. With more than 20 locations across New Jersey, Connecticut, Massachusetts, and the Washington, D.C., area, RCCA remains committed to delivering expert oncology care and patient education.
To learn more about multiple myeloma risk factors or schedule a consultation, contact RCCA at 844-346-7222 or contact RCCA today.
Sources:
For more information or to schedule an appointment,
call 844-346-7222. You can also schedule an appointment by calling the RCCA location nearest you.

Breast cancer treatment options vary from patient to patient. Physicians must weigh many factors when considering which approach is best for a particular patient. Those

Prostate cancer treatments are constantly improving. Groundbreaking new medications provide longer survival and fewer side effects than ever before. Keeping track of the advances in

Increased Survival in Colorectal Cancer: RCCA Oncologists Tell How Doctors &Patients Are Driving the Trend The colorectal cancer death rate has dropped by more than 30%
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.